A highly portable, electricity-free EPAP device that offers a clinically validated alternative to CPAP for travelers and patients with mild to moderate sleep apnea.

Bongo Rx Review: Portable EPAP Therapy for OSA and Snoring

Published Mar 21, 2026
|
Reviewed by Dustin Cotliar, MD, MPH, MD
|
Testing N/A
|
Evidence Strong Clinical Evidence
PEER REVIEWED

Bongo Rx represents a specialized class of sleep therapy known as Expiratory Positive Airway Pressure (EPAP). Unlike mandibular advancement devices that physically reposition the jaw, Bongo Rx utilizes a set of soft silicone nasal seals containing one-way valves. During inhalation, these valves open freely to allow a full breath; during exhalation, they close and redirect air through specifically engineered vent holes. This mechanical redirection creates backpressure that acts as a pneumatic stent, effectively keeping the airway open until the next breath cycle begins. Clinically, the device has been reviewed and cleared by the FDA for the treatment of mild to moderate Obstructive Sleep Apnea (OSA). It is particularly noted for its high patient acceptance due to the absence of machines, masks, or hoses, and its ability to function without electricity makes it a premier option for travelers and campers. Clinical testing demonstrated that the Apnea-Hypopnea Index (AHI) was significantly reduced compared to baseline diagnostics, with no serious adverse events reported.

Recommended Strong Clinical Evidence FDA 510(k) Cleared
Bongo Rx EPAP Device - Medical Device

Bongo Rx EPAP Device

Bongo Rx

$199.00
+ $5.00/mo
88 /100

Our Score

Clinical Performance Metrics

Quantitative assessment based on clinical testing protocols

Snoring Reduction

Effectively stabilizes the airway using expiratory backpressure, significantly reducing snoring associated with airway collapse.

87/100

Wearing Comfort

The soft silicone seals are well-tolerated, though users must acclimate to the sensation of breathing against pressure.

85/100

Ease of Use

Extremely simple; requires no assembly, power, or complex fitting beyond selecting the correct nasal seal size.

94/100

Value for Money

High value for CPAP-intolerant patients and frequent travelers, supported by its reusable and durable design.

85/100

Quick Take

Key findings from our clinical evaluation

+
Strengths

  • Clinically tested and FDA-cleared for mild to moderate OSA
  • No machines, masks, hoses, or electricity required
  • Small enough to fit in a shirt pocket for maximum portability
  • Allows users to sleep comfortably in virtually any position
  • Reusable and easy to clean with standard soap and water

Limitations

  • Requires a physician's prescription for purchase
  • May not be suitable for patients with severe OSA or significant comorbidities
  • Requires an adjustment period to get used to expiratory resistance

Real-World Usage

Practical considerations for daily operation

Daily Routine Impact

Fits seamlessly into a nightly routine and is ideal for active lifestyles. It requires no power outlet, allowing users to maintain therapy while traveling or camping without bulky equipment.

Learning Curve

Master in a day

Maintenance

Daily cleaning with mild soap and water; air dry before next use. Seals are reusable but should be inspected for wear.

Portability

Superior; the most portable medical-grade OSA intervention evaluated, requiring only the pocket-sized inserts.

Manual Use

Purely mechanical pneumatic operation; effectiveness is immediate upon correct insertion and does not rely on software.

Cost & Coverage Analysis

Financial considerations and HSA / FSA eligibility

Pricing Breakdown

Device Price $199.00
Replacement Nasal Inserts (Full replacement starter kit)
$199.00 / yearly
Cleaning Supplies (Mild soap and water for daily cleaning [cite: 1960])
$5.00 / monthly
HSA / FSA Eligibility Rarely Eligible

1-Year Total

$259.00

3-Year Total

$379.00

HSA/FSA Guidance

Often available to veterans through the VA health system; check with private providers for reimbursement as a CPAP alternative.

Cost Comparison

Competitively priced compared to other prescription oral appliances and significantly cheaper than CPAP machine setups.

Patient Suitability

Clinical indications and contraindications

Indicated For

  • Travelers and campers needing a portable OSA solution
  • CPAP-intolerant patients seeking a less invasive option
  • Users who prefer to sleep in multiple or active positions

Contraindications

  • Individuals with severe nasal congestion or anatomical blockages
  • Patients diagnosed with severe obstructive sleep apnea

Age Considerations

Indicated for use in adults 18 years of age and older.

Clinical Efficacy Assessment

Evidence-based evaluation of clinical performance

Snoring Frequency Reduction

Measures the percentage reduction in snoring episodes recorded overnight.

Clinical reports indicate high efficacy in reducing snoring duration and intensity through pneumatic airway stenting.

Sleep Quality Improvement

Assess improvement in restorative sleep and reduction in daytime fatigue.

Patients report feeling as rested as they do with standard CPAP equipment, with improved daytime alertness.

AHI Improvement (if applicable)

Measures the reduction in the Apnea-Hypopnea Index (AHI) for OSA patients.

Clinical testing reviewed by the FDA demonstrated significant AHI reduction across the test population.

Partner-Reported Improvement

Evaluates the impact of the device on the bed partner's sleep environment.

The device operates quietly and is discreet enough that bed partners often do not notice its presence.

Comparative Performance

Ranked #12 of 20 clinically evaluated anti-snoring devices devices

1
ProSomnus EVO Sleep and Snore Device

ProSomnus EVO Sleep and Snore Device

ProSomnus

Top Rated
2
Panthera Classic (D-SAD)

Panthera Classic (D-SAD)

Panthera Dental

3
ZQuiet Anti-Snoring Mouthpiece

ZQuiet Anti-Snoring Mouthpiece

ZQuiet

12
Bongo Rx EPAP Device

Bongo Rx EPAP Device

Bongo Rx

You're viewing this
88 /100

Clinical Context

Our #1-ranked anti-snoring devices device demonstrated superior performance across key clinical metrics. Compare detailed specifications to make an evidence-based selection.

Clinical Recommendation

Final assessment and prescribing guidance

Bongo Rx is an innovative and effective CPAP alternative for those with mild to moderate OSA. Its simplicity, clinical validation, and extreme portability make it a top choice for mobile patients.

Recommend If

You travel frequently and want a prescription-grade sleep apnea solution that doesn't require electricity or bulky gear.

Avoid If

You have severe OSA or find it difficult to breathe against even slight resistance through your nose.

Clinical Summary

88 /100

Composite Score

Recommended

Recommendation

$199

Price Point

Evidence: Strong
Tested: N/A

Where to Buy

Verified purchase options and current availability

The DME Source

Price: $199.00
Standard shipping

Prescription required; HSA/FSA eligible[cite: 1559, 1952, 2222].

Shop Now

CPAP.com

Price: $199.00
Fast shipping options available

Requires valid prescription from a local doctor or telehealth provider[cite: 1555, 1952].

Shop Now

1800CPAP.com

Price: $199.00
Standard shipping

FSA/HSA accepted[cite: 1952, 2222].

Shop Now

Important Information

  • • Prices and availability subject to change
  • • Some devices may require a prescription
  • • HSA / FSA eligibility: Rarely Eligible
  • • Purchase from authorized retailers for warranty protection
Visit Manufacturer Website
Testing Methodology

Evaluation of FDA-reviewed clinical testing data demonstrating AHI reduction and safety profiles for EPAP therapy.

Medical Review: Physicians highlight Bongo Rx for its high compliance rates and ease of initiation, as it avoids the lengthy setup, titration, or surgical requirements of other OSA treatments.

Medical Disclaimer

This review is for informational purposes only and does not constitute medical advice. Individual results may vary. Always consult with healthcare professionals before making medical device decisions. Clinical recommendations should be individualized based on patient-specific factors.